SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celera Genomics (CRA)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: xbrent who wrote (327)5/10/2000 2:26:00 AM
From: allen menglin chen  Read Replies (2) of 746
 
xbrent, could u PM me how u find that out from SG Cown? Thanks.

My source, Hung_like_John_Holmes, told me it should be Thursday, with 80% certainty some news, or progress report.

1. CRA is a key presenter Morgan Stanley Genomics conference. (Maria CNBC Market Week)

2. "Rival Celera Genomics (NYSE: CRA) has been involved in a highly publicized effort to map the genome. The company claims to be ahead of the government effort in locating the letters and mapping many of the genes and may issue a progress report at a genomic conference that starts this Thursday at Cold Spring Harbor Laboratory in Long Island, New York."
redherring.com
nucleus.cshl.org

3. Maybe a CRA article in this Thursday's new article (WSJ Monday A2 bottom box) nature.com

4. From early April, Venter claimed 3-6 weeks for the assembly step, now 4.5 weeks have passed.
newsvote.bbc.co.uk
streetadvisor.com
streetadvisor.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext